Abstract
A novel protein tyrosine phosphatase 1B (PTP1B) inhibitor,FYGL, extracted fromGanoderma lucidum, was first reported to have an efficient hypoglycemic effect and high safetyin vivoin our previous study.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
